Martina Lichtenfels (BRA
Bachelor of Biological Sciences (PUCRS). PhD in Medical Sciences from UFRGS with a sandwich period at the German Research Cancer Center (DKFZ, Heidelberg). Postdoc in Pharmaceutical Biotechnology at Ludwig-Maximillians University (LMU, Munich). Researcher at Ziel Biosciences, and collaborating researcher at the Breast Group at Hospital São Lucas at PUCRS.
2:20PM - 2:30PM
MAIN AUDITORIUM
What happens in residual disease after neoadjuvant chemotherapy? Efficacy of a novel in vitro breast cancer chemoresistance platform to demonstrate high resistance to drugs
8:20AM - 8:30AM
MAIN AUDITORIUM
Drug resistance in luminal breast tumors: results of a novel in vitro breast cancer chemoresistance platform
Martina Lichtenfels (BRA)
8:40AM FROM 8:43AM
SIMULTANEOUS ROOM
Breast cancer biomarkers of resistance to neoadjuvant chemotherapy
10:30AM FROM 11:00AM
SIMULTANEOUS ROOM
Commented poster session 2
Coordinator:
MARTINA LICHTENFELS (BRA)
Discussants:
CARLOS ALEXANDRE VIEIRA (BRA)
JOSÉ LUIZ PEDRINI (BRA)
